Brain Cancer Research

1. Palethorpe, Helen,Shard, Chloe, Ryan, Conor, Wenholz, Daniel, Truong, Quach, Scheer, Kaitlin, Skarne, Niclas, Patil, Ashwini, Ormsby, Rebecca, Poonnoose, Santosh, Alexander, Kimberley, Gan, Hui, Day, Bryan, Kumar, Naresh, Wilkinson, John, and Gomez, Guillermo (2024). RAPID PROCESSING AND BIOBANKING OF RESECTED BRAIN TUMOR TISSUE TO GENERATE PATIENT-DERIVED BRAIN TUMOR EXPLANT ORGANOIDS (GBOS) FOR PRECLINICAL STUDIES. CARY: OXFORD UNIV PRESS INC. https://doi.org/10.1093/neuonc/noae165.1284
2. Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MLP, O’Rourke DM, Mohan S, Davatzikos C.Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study. Neuro Oncol. 2024 Dec 12;. doi: 10.1093/neuonc/noae260. [Epub ahead of print] PubMed PMID: 39665363.
3. Loh C, Zheng Y, Alzoubi I, Alexander KL, Lee M, Cai W, Song Y, McDonald K, Nowak AK, Banati RB, Graeber MB.Microglia and brain macrophages are differentially associated with tumor necrosis in glioblastoma: A link to tumor progression. Oncology Research. 2024 November. doi: doi:10.32604/or.2024.056436.
4. Hallal SM, Sida LA, Tűzesi CÁ, Shivalingam B, Sim HW, Buckland ME, Satgunaseelan L, Alexander KL.Size matters: Biomolecular compositions of small and large extracellular vesicles in the urine of glioblastoma patients. J Extracell Biol. 2024 Nov;3(11):e70021. doi: 10.1002/jex2.70021. eCollection 2024 Nov. PubMed PMID: 39554867; PubMed Central PMCID: PMC11565258.
5. Chan N, Madani D, Allan RS, Sy J, Satgunaseelan L. Hidden identities in plurihormonal pituitary neuroendocrine tumours: expanding the spectrum of the ‘silent corticogonadotroph adenoma’, Pathology 2024 DOI:1016/j.pathol.2024.08.015
6. Gongala S, Garcia JA, Korakavi N, Patil N, Akbari H, Sloan A, Barnholtz-Sloan JS, Sun J, Griffith B, Poisson LM, Booth TC, Jain R, Mohan S, Nasralla MP, Bakas S, Tippareddy C, Puig J, Palmer JD, Shi W, Colen RR, Sotiras A, Ahn SS, Park YW, Davatzikos C, Badve C.Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024 Sep 9;45(9):1299-1307. doi: 10.3174/ajnr.A8319. PubMed PMID: 38684319; PubMed Central PMCID: PMC11392364.
7. Satgunaseelan L, Lee M, Iannuzzi S, Hallal S, Deang K, Stanceski K, Wei H, Mason S, Shivalingam B, Sim HW, Buckland ME, Alexander KL.‘The Reports of My Death Are Greatly Exaggerated’-Evaluating the Effect of Necrosis on MGMT Promoter Methylation Testing in High-Grade Glioma.Cancers (Basel). 2024 May 16;16(10). doi: 10.3390/cancers16101906. PubMed PMID: 38791984; PubMed Central PMCID: PMC11120496.
8. Satgunaseelan L, Sy J, Shivalingam B, Sim HW, Alexander KL, Buckland ME.Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play. Pathology. 2024 Mar;56(2):158-169. doi: 10.1016/j.pathol.2023.11.003. Epub 2023 Dec 12.  PubMed PMID: 38233331.
9. Hallal SM, Tűzesi Á, Sida LA, Xian E, Madani D, Muralidharan K, Shivalingam B, Buckland ME, Satgunaseelan L, Alexander KL. Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a ‘liquid gold’ biopsy.Br J Cancer. 2024 Mar;130(5):836-851. doi: 10.1038/s41416-023-02548-9. Epub 2024 Jan 11. PubMed PMID: 38212481; PubMed Central PMCID: PMC10912426.
10. Ng FJ, Wang W, Satgunaseelan S, Verma N. Rapid Vision Loss Due to Multifocal Glioma: A Diagnostic Challenge Opthalmology and Therapy 2024 May;13(13):1399-1405
11. Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku’ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ, Théry C, Witwer KW.Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. PubMed PMID: 38326288; PubMed Central PMCID: PMC10850029.
12. Lee MD, Patel SH, Mohan S, Akbari H, Bakas S, Nasrallah MP, Calabrese E, Rudie J, Villanueva-Meyer J, LaMontagne P, Marcus DS, Colen RR, Balana C, Choi YS, Badve C, Barnholtz-Sloan JS, Sloan AE, Booth TC, Palmer JD, Dicker AP, Flanders AE, Shi W, Griffith B, Poisson LM, Chakravarti A, Mahajan A, Chang S, Orringer D, Davatzikos C, Jain R. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Neuroradiology. 2023 Sep;65(9):1343-1352. doi: 10.1007/s00234-023-03196-9. Epub 2023 Jul 19. PubMed PMID: 37468750; PubMed Central PMCID: PMC11058040.

12. Tűzesi Á, Hallal S, Satgunaseelan L, Buckland ME, Alexander KL. Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics.Cancers (Basel). 2023 Feb 15;15(4). doi: 10.3390/cancers15041232.  PubMed PMID: 36831575; PubMed Central PMCID: PMC9954771.
13. Shard C, Alexander K, Gan H, Gomez G.Genetic evolution and cellular interactions within the tumour microenvironment determine glioblastoma progression.  2023; 12:52.
14. Stanceski K, Alexander K, Satgunaseelan L.Cellular migration in IDH-wildtype glioblastoma: a case series on the genomics of amoeboid movement and its prognostic significance.  2023; 55:S75.
15. Akbari H, Bakas S, Garcia J, Kazerooni A, Sako C, Villanueva-Meyer J, Baid U, Mamourian E, Brem S, Lustig R.NIMG-13. ROBUSTNESS OF PROGNOSTIC STRATIFICATION IN DE NOVO GLIOBLASTOMA PATIENTS ACROSS 22 GEOGRAPHICALLY DISTINCT INSTITUTIONS: INSIGHTS FROM THE RESPOND CONSORTIUM. Neuro-Oncology. 2023; 25(Supplement_5):v187-v187
16. Hallal S, Tűzesi Á, Grau GE, Buckland ME, Alexander KL.Understanding the extracellular vesicle surface for clinical molecular biology. J Extracell Vesicles. 2022 Oct;11(10):e12260. doi: 10.1002/jev2.12260.  PubMed PMID: 36239734; PubMed Central PMCID: PMC9563386.
17. Alzoubi I, Bao G, Zhang R, Loh C, Zheng Y, Cherepanoff S, Gracie G, Lee M, Kuligowski M, Alexander KL, Buckland ME, Wang X, Graeber MB.An Open-Source AI Framework for the Analysis of Single Cells in Whole-Slide Images with a Note on CD276 in Glioblastoma. Cancers (Basel). 2022 Jul 15;14(14). doi: 10.3390/cancers14143441. PubMed PMID: 35884502; PubMed Central PMCID: PMC9316952.
18. Griffin CP, Paul CL, Alexander KL, Walker MM, Hondermarck H, Lynam J. Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole.Neurooncol Adv.2022 Jan-Dec;4(1):vdab168. doi: 10.1093/noajnl/vdab168. eCollection 2022 Jan-Dec.  PubMed PMID: 35047819; PubMed Central PMCID: PMC8760897.
19. Hallal S, Ebrahim Khani S, Wei H, Lee MYT, Sim HW, Sy J, Shivalingam B, Buckland ME, Alexander-Kaufman KL.Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients. Int J Mol Sci. 2020 Jul 13;21(14). doi: 10.3390/ijms21144954. PubMed PMID: 32668808; PubMed Central PMCID: PMC7404297.
20. Hallal S, Azimi A, Wei H, Ho N, Lee MYT, Sim HW, Sy J, Shivalingam B, Buckland ME, Alexander-Kaufman KL.A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance. Int J Mol Sci. 2020 Jul 3;21(13). doi: 10.3390/ijms21134754. PubMed PMID: 32635403; PubMed Central PMCID: PMC7369771.
21. Hallal S, Mallawaaratchy DM, Wei H, Ebrahimkhani S, Stringer BW, Day BW, Boyd AW, Guillemin GJ, Buckland ME, Kaufman KL.Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways. Mol Neurobiol. 2019 Jun;56(6):4566-4581. doi: 10.1007/s12035-018-1385-1. Epub 2018 Oct 23. PubMed PMID: 30353492; PubMed Central PMCID: PMC6505517.
22. Hallal S, Ebrahimkhani S, Shivalingam B, Graeber MB, Kaufman KL, Buckland ME.The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring. Brain Tumor Pathol. 2019 Apr;36(2):29-39. doi: 10.1007/s10014-019-00335-0. Epub 2019 Mar 11.  PubMed PMID: 30859343.
23. Hallal S, Russell BP, Wei H, Lee MYT, Toon CW, Sy J, Shivalingam B, Buckland ME, Kaufman KL.Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance. Proteomics. 2019 Jan;19(1-2):e1800157. doi: 10.1002/pmic.201800157. PubMed PMID: 30451371.
24. Ebrahimkhani S, Vafaee F, Hallal S, Wei H, Lee MYT, Young PE, Satgunaseelan L, Beadnall H, Barnett MH, Shivalingam B, Suter CM, Buckland ME, Kaufman KL.Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis. NPJ Precis Oncol.2018;2:28. doi: 10.1038/s41698-018-0071-0. eCollection 2018. PubMed PMID: 30564636; PubMed Central PMCID: PMC6290767.
25. Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL.Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. J Neurooncol. 2017 Jan;131(2):233-244. doi: 10.1007/s11060-016-2298-3. Epub 2016 Oct 21. PubMed PMID: 27770278; PubMed Central PMCID: PMC5306193.
26. Mallawaaratchy DM, Buckland ME, McDonald KL, Li CC, Ly L, Sykes EK, Christopherson RI, Kaufman KL.Membrane proteome analysis of glioblastoma cell invasion. J Neuropathol Exp Neurol. 2015 May;74(5):425-41. doi: 10.1097/NEN.0000000000000187. PubMed PMID: 25853691.
27. Wilcox P, Li CC, Lee M, Shivalingam B, Brennan J, Suter CM, Kaufman K, Lum T, Buckland ME.Oligoastrocytomas: throwing the baby out with the bathwater?. Acta Neuropathol. 2015 Jan;129(1):147-9. doi: 10.1007/s00401-014-1353-4. Epub 2014 Oct 11. PubMed PMID: 25304041.

1. Gan, H. K., Day, B. W., Harrup, R., Johns, T. G., Lwin, Z., Scott, A. M., Sim, H. W. & Koh, E. S. 2023. Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future. Current Oncology Reports, 25, 589-598.
2. Satgunaseelan, L., Sy, J., Shivalingam, B., Sim, H. W., Alexander, K. L. & Buckland, M. E. 2024. Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play. Pathology, 56, 158-169.
3. Sim, H. W., Lorrey, S. & Khasraw, M. 2023. Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas. Current Neurology and Neuroscience Reports, 23, 263-276.
4. Sim, H. W., Wachsmuth, L., Barnes, E. H., Yip, S., Koh, E. S., Hall, M., Jennens, R., Ashley, D. M., Verhaak, R. G., Heimberger, A. B., Rosenthal, M. A., Hovey, E. J., Ellingson, B. M., Tognela, A., Gan, H. K., Wheeler, H., Back, M., Mcdonald, K. L., Long, A., Cuff, K., Begbie, S., Gedye, C., Mislang, A., Le, H., Johnson, M. O., Kong, B. Y., Simes, J. R., Lwin, Z. & Khasraw, M. 2023. Nutmeg: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma. Neuro-Oncology Advances,
5. Trinder, S. M., Mckay, C., Power, P., Topp, M., Chan, B., Valvi, S., Mccowage, G., Govender, D., Kirby, M., Ziegler, D. S., Manoharan, N., Hassall, T., Kellie, S., Heath, J., Alvaro, F., Wood, P., Laughton, S., Tsui, K., Dodgshun, A., Eisenstat, D. D., Endersby, R., Luen, S. J., Koh, E. S., Sim, H. W., Kong, B., Gottardo, N. G., Whittle, J. R., Khuong-Quang, D. A. & Hansford, J. R. 2023. BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience. Frontiers in Oncology,
6. Tűzesi, Á., Hallal, S., Satgunaseelan, L., Buckland, M. E. & Alexander, K. L. 2023. Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics. Cancers,

1. Alzoubi, I., Bao, G., Zhang, R., Loh, C., Zheng, Y., Cherepanoff, S., Gracie, G., Lee, M., Kuligowski, M., Alexander, K. L., Buckland, M. E., Wang, X. & Graeber, M. B. 2022. An Open-Source AI Framework for the Analysis of Single Cells in Whole-Slide Images with a Note on CD276 in Glioblastoma. Cancers,
2. Griffin, C. P., Paul, C. L., Alexander, K. L., Walker, M. M., Hondermarck, H. & Lynam, J. 2022. Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole. Neuro-Oncology Advances,
3. Halkett, G. K. B., Breen, L. J., Berg, M., Sampson, R., Sim, H. W., Gan, H. K., Kong, B. Y., Nowak, A. K., Day, B. W., Harrup, R., James, M., Saran, F., Mcfarlane, B., Tse, C. & Koh, E. S. 2022. Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers. Current Oncology, 29, 9928-9955.
4. Hallal, S., Tűzesi, Á., Grau, G. E., Buckland, M. E. & Alexander, K. L. 2022. Understanding the extracellular vesicle surface for clinical molecular biology. Journal of Extracellular Vesicles,
5. Kong, B. Y., Carter, C., Nowak, A. K., Hovey, E., Lwin, Z., Haghighi, N., Gan, H. K., Sim, H. W., Ziegler, D. S., Barton, K., Parkinson, J., Leonard, R., Khasraw, M. & Foote, M. 2022. Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspective. Asia-Pacific Journal of Clinical Oncology, 18, 259-266.
6. Kong, B. Y., Sim, H. W., Barnes, E. H., Nowak, A. K., Hovey, E. J., Jeffree, R., Harrup, R., Parkinson, J., Gan, H. K., Pinkham, M. B., Yip, S., Hall, M., Tu, E., Carter, C., Koh, E. S., Lwin, Z., Dowling, A., Simes, J. S. & Gedye, C. 2022. Multi-Arm GlioblastoMa Australasia (MAGMA): Protocol for a multiarm randomised clinical trial for people affected by glioblastoma. BMJ Open,
7. Sim, H. W., Galanis, E. & Khasraw, M. 2022. PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities. Cancers,
8. Thompson, J. F., Williams, G. J. & Hong, A. M. 2022. Radiation therapy for melanoma brain metastases: a systematic review. Radiology and Oncology, 56, 267-284.
9. Wilmott, J. S., Tawbi, H., Engh, J. A., Amankulor, N. M., Shivalingam, B., Banerjee, H., Vergara, I. A., Lee, H., Johansson, P. A., Ferguson, P. M., Saiag, P., Robert, C., Grob, J. J., Butterfield, L. H., Scolyer, R. A., Kirkwood, J. M., Long, G. V. & Davies, M. A. 2023. Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. Clinical Cancer Research, 29, 521-531.

1. Choi, S., Hong, A., Wang, T., Lo, S., Chen, B., Silva, I., Kapoor, R., Hsiao, E., Fogarty, G. B., Carlino, M. S., Menzies, A. M., Long, G. V. & Shivalingam, B. S. 2021. Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location. Strahlentherapie und Onkologie, 197, 1104-1112.
2. Hong, A. M., Waldstein, C., Shivalingam, B., Carlino, M. S., Atkinson, V., Kefford, R. F., Mcarthur, G. A., Menzies, A. M., Thompson, J. F. & Long, G. V. 2021. Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia. European Journal of Cancer, 142, 10-17.
3. Kong, B. Y., Sim, H. W., Nowak, A. K., Yip, S., Barnes, E. H., Day, B. W., Buckland, M. E., Verhaak, R., Johns, T., Robinson, C., Thomas, M. A., Giardina, T., Lwin, Z., Scott, A. M., Parkinson, J., Jeffree, R., Lourenco, R. D. A., Hovey, E. J., Cher, L. M., Kichendasse, G., Khasraw, M., Hall, M., Tu, E., Amanuel, B., Koh, E. S. & Gan, H. K. 2021. LUMOS – Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study. BMJ Open,
4. Sim, H. W., Mcdonald, K. L., Lwin, Z., Barnes, E. H., Rosenthal, M., Foote, M. C., Koh, E. S., Back, M., Wheeler, H., Sulman, E. P., Buckland, M. E., Fisher, L., Leonard, R., Hall, M., Ashley, D. M., Yip, S., Simes, J. & Khasraw, M. 2021. A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: The VERTU study. Neuro-Oncology, 23, 1736-1749.
5. Sim, H. W., Nowak, A. K., Lwin, Z. & Khasraw, M. 2021. Management of glioblastoma: An Australian perspective. Chinese Clinical Oncology,

AZIMI, A., KAUFMAN, K. L., KIM, J., ALI, M., MANN, G. J. & FERNANDEZ-PENAS, P. 2020. Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors. J Dermatol Sci, 99, 9-16.

AZIMI, A., YANG, P., ALI, M., HOWARD, V., MANN, G. J., KAUFMAN, K. L. & FERNANDEZ-PENAS, P. 2020. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen’s Disease, and Cutaneous Squamous Cell Carcinoma. J Invest Dermatol, 140, 212-222.e11.

FISH, C., SY, J. & WONG, J. 2020. High mitotic activity in a capillary hemangioma of the cauda equina: Case report and review of the literature. Clin Neuropathol, 39, 135-138.

HALLAL, S., AZIMI, A., WEI, H., HO, N., LEE, M. Y. T., SIM, H. W., SY, J., SHIVALINGAM, B., BUCKLAND, M. E. & ALEXANDER-KAUFMAN, K. L. 2020. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance. Int J Mol Sci, 21.

HALLAL, S., EBRAHIM KHANI, S., WEI, H., LEE, M. Y. T., SIM, H. W., SY, J., SHIVALINGAM, B., BUCKLAND, M. E. & ALEXANDER-KAUFMAN, K. L. 2020. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients. Int J Mol Sci, 21.

MORRISON, T., JUKES, A. & WONG, J. 2020. Rupture from cavernous internal carotid artery pseudoaneurysm 11 years after transsphenoidal surgery. J Clin Neurosci, 79, 266-268.

ORGAIN, C. A., KUAN, E. C., ALVARADO, R., ADAPPA, N. D., JONKER, B. P., LEE, J. Y. K., PALMER, J. N., WINDER, M. & HARVEY, R. J. 2020. Smell Preservation following Unilateral Endoscopic Transnasal Approach to Resection of Olfactory Groove Meningioma: A Multi-institutional Experience. J Neurol Surg B Skull Base, 81, 263-267.

OVENS, C., DEAN, B., GZELL, C., PATANJALI, N., JONKER, B., O’CONNOR, M., ESTOESTA, P., DEMARTIN, T. & FRASER, C. 2020. Optimal management in optic nerve sheath meningioma – A multicentre study and pooled data analysis. J Clin Neurosci, 80, 162-168.

SHKLOVSKAYA, E., LEE, J. H., LIM, S. Y., STEWART, A., PEDERSEN, B., FERGUSON, P., SAW, R. P., THOMPSON, J. F., SHIVALINGAM, B., CARLINO, M. S., SCOLYER, R. A., MENZIES, A. M., LONG, G. V., KEFFORD, R. F. & RIZOS, H. 2020. Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma. Cancers (Basel), 12.

SIM, H. W., NOWAK, A. K., LWIN, Z. & KHASRAW, M. 2020. Management of glioblastoma: an Australian perspective. Chin Clin Oncol.

STROUD, A., DHALIWAL, P., ALVARADO, R., WINDER, M. J., JONKER, B. P., GRAYSON, J. W., HAMIZAN, A., HARVEY, R. J. & MCCORMACK, A. 2020. Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis. Pituitary, 23, 595-609.

WANG, M., JONKER, B., KILLEN, L., BOGUM, Y., MCCORMACK, A. & BISHAY, R. H. 2020. Fatal high-grade skull osteosarcoma 30 years following radiotherapy for Cushing’s disease. Endocrinol Diabetes Metab Case Rep, 2020.

AZIMI, A., ALI, M., KAUFMAN, K. L., MANN, G. J. & FERNANDEZ-PENAS, P. 2019. Tape Stripped Stratum Corneum Samples Prove to be Suitable for Comprehensive Proteomic Investigation of Actinic Keratosis. Proteomics Clin Appl, 13, e1800084.

HALLAL, S., EBRAHIMKHANI, S., SHIVALINGAM, B., GRAEBER, M. B., KAUFMAN, K. L. & BUCKLAND, M. E. 2019. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring. Brain Tumor Pathol, 36, 29-39.

HALLAL, S., MALLAWAARATCHY, D. M., WEI, H., EBRAHIMKHANI, S., STRINGER, B. W., DAY, B. W., BOYD, A. W., GUILLEMIN, G. J., BUCKLAND, M. E. & KAUFMAN, K. L. 2019. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways. Mol Neurobiol, 56, 4566-4581.

HALLAL, S., RUSSELL, B. P., WEI, H., LEE, M. Y. T., TOON, C. W., SY, J., SHIVALINGAM, B., BUCKLAND, M. E. & KAUFMAN, K. L. 2019. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance. Proteomics, 19, e1800157.

HONG, A. M., FOGARTY, G. B., DOLVEN-JACOBSEN, K., BURMEISTER, B. H., LO, S. N., HAYDU, L. E., VARDY, J. L., NOWAK, A. K., DHILLON, H. M., AHMED, T., SHIVALINGAM, B., LONG, G. V., MENZIES, A. M., HRUBY, G., DRUMMOND, K. J., MANDEL, C., MIDDLETON, M. R., REISSE, C. H., PATON, E. J., STEEL, V., WILLIAMS, N. C., SCOLYER, R. A., MORTON, R. L. & THOMPSON, J. F. 2019. Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial. J Clin Oncol, 37, 3132-3141.

OLAFSON, L. R., SIDDELL, A. H., FIELD, K. M., BYRNES, M., RAPKINS, R. W., NG, B., NIXDORF, S., BARNES, E. H., JOHNS, T. G., YIP, S., SIMES, J., NOWAK, A. K., ROSENTHAL, M. A. & MCDONALD, K. L. 2019. Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial. J Clin Neurosci,
70, 157-163.

YOUNG, A. S., JONKER, B. & WELGAMPOLA, M. S. 2019. Vestibular paroxysmia presenting with irritative nystagmus. Neurology, 92, 723-724.